New trials may cut clopidogrel use

A trio of late-breaking clinical trials could change standard drug treatment for patients undergoing percutaneous coronary intervention, or PCI.

Related Videos
Dr. Charles Lee
© 2023 MJH Life Sciences

All rights reserved.